Yekaterina Chudnovsky - 22 Aug 2023 Form 4 Insider Report for Immix Biopharma, Inc. (IMMX)

Role
Director, 10%+ Owner
Signature
/s/ Yekaterina Chudnovsky
Issuer symbol
IMMX
Transactions as of
22 Aug 2023
Net transactions value
$0
Form type
4
Filing time
23 Aug 2023, 16:28:40 UTC
Previous filing
12 Jun 2023
Next filing
26 Dec 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IMMX Stock Option (Right to Buy) Award $0 +20,000 $0.000000 20,000 22 Aug 2023 Common Stock 20,000 $1.80 Direct F1
transaction IMMX Stock Option (Right to Buy) Award $0 +16,670 $0.000000 16,670 22 Aug 2023 Common Stock 16,670 $1.80 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Stock Option will vest in thirty-six (36) equal monthly installments following the date of grant, subject to the Reporting Person's continued service on the Board of Directors.
F2 The Stock Option will vest in ten (10) equal monthly installments following the date of grant and any remaining unvested shares will become fully vested and exercisable on the date of the 2024 annual shareholder meeting, subject to the Reporting Person's continued service on the Board of Directors.